Latest News

  • Alkermes Announces Initiation of Phase 1 Clinical Study of ALKS 7106 for Treatment of Pain Read More
  • Alkermes Submits New Drug Application to FDA for Aripiprazole Lauroxil for Treatment of Schizophrenia Read More
  • Alkermes plc Reports Second Quarter 2014 Financial Results Read More

Investors

Learn More

Working at Alkermes

Join Our Team